Product Name

  • Name

    Hydralazine

  • EINECS 201-680-3
  • CAS No. 86-54-4
  • Density 1.2583 (rough estimate)
  • Solubility 4.8mg/L(22.5 oC)
  • Melting Point 172 ºC
  • Formula C8H8 N4
  • Boiling Point 276.07°C (rough estimate)
  • Molecular Weight 160.178
  • Flash Point
  • Transport Information
  • Appearance Yellow needles from methanol.
  • Safety Poison by ingestion, intravenous, intraperitoneal, and subcutaneous routes. Human systemic effects by ingestion: allergic dermatitis, cardiomyopathy, changes in coronary arteries. Human teratogenic effects by an unspecified route: developmental abnormalities of the blood and lymphatic system. Questionable carcinogen. Mutation data reported. When heated to decomposition it emits toxic fumes of NOx.
  • Risk Codes
  • Molecular Structure Molecular Structure of 86-54-4 (Hydralazine)
  • Hazard Symbols
  • Synonyms 1(2H)-Phthalazinone,hydrazone (9CI); Phthalazine, 1-hydrazino- (6CI,8CI); 1-Hydrazinophthalazine;1-Phthalazinylhydrazine; Apresolin; Apresoline; Apressin; Apressin(pharmaceutical); Aprezolin; Ba 5968; C 5968; Ciba 5968; Hidralazin;Hipoftalin; Hydralazin; Hydralazine; Hypophthalin; NSC 126699
  • PSA 63.83000
  • LogP 1.68870

Hydralazine Chemical Properties

IUPAC Name: Phthalazin-1-ylhydrazine
Product Name: Hydralazine
The MF of Hydralazine (CAS NO.86-54-4) is C8H8N4.

                        
The MW of Hydralazine (CAS NO.86-54-4) is 160.17592.
Synonyms of Hydralazine (CAS NO.86-54-4): 1(2H)-Phthalazinone, hydrazone, (1Z)- ; 1-Hydrazinophthalazine ; Phthalazin-1-yl-hydrazine ; [2H-Phthalazin-(1Z)-Ylidene]-Hydrazine Hydrochloride ; (2H)-Phthalazinone, hydrazone, monohydrochloride ; (2H)-Phthalazinone, hydrazone ; 1-Phthalazinylhydrazine 
Product Categories: Amines;Aromatics;Heterocycles;Inhibitors
Apperance: Yiellow Solid
Index of Refraction: 1.777 
EINECS: 201-680-3
Density: 1.373 g/ml 
Flash Point: 251.3 °C
Boiling Point: 491.9 °C
Melting Point: 172 °C

Hydralazine Uses

  Hydralazine (CAS NO.86-54-4) inhibits DNA methyltransferase and modulates epigenetic regulation of gene expression.Used as Non-selective MAO-A/B inhibitor, semicarbazide-sensitive amine oxidase inhibitor and antihypertensive.

Hydralazine Production

Preparation Products: Hyaluronidase

Hydralazine Toxicity Data With Reference

1.    

mma-sat 500 µg/plate

    MUREAV    Mutation Research. 66 (1979),247.
2.    

slt-dmg-unr 200 mmol/L/6H

    MUREAV    Mutation Research. 120 (1983),233.
3.    

orl-man TDLo:2086 mg/kg/2Y-I:SKN

    BMJOAE    British Medical Journal. 289 (1984),410.
4.    

orl-wmn TDLo:730 mg/kg/2Y-I:SKN

    BMJOAE    British Medical Journal. 289 (1984),410.
5.    

ims-man TDLo:89 µg/kg:CVS

    EJPEDT    European Journal of Pediatrics. 145 (1986),318.
6.    

orl-rat LD50:90 mg/kg

    PLRCAT    Pharmacological Research Communications. 8 (1976),295.
7.    

ipr-rat LD50:25 mg/kg

    JPETAB    Journal of Pharmacology and Experimental Therapeutics. 143 (1964),7.
8.    

ivn-rat LD50:34 mg/kg

    JAPMA8    Journal of the American Pharmaceutical Association, Scientific Edition. 40 (1951),559.
9.    

orl-mus LD50:122 mg/kg

    PLRCAT    Pharmacological Research Communications. 8 (1976),295.
10.    

ipr-mus LD50:100 mg/kg

    JMCMAR    Journal of Medicinal Chemistry. 22 (1979),671.
11.  

Hydralazine Consensus Reports

IARC Cancer Review: Group 3 IMEMDT    IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 7 , 1987,p. 222.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Human Inadequate Evidence IMEMDT    IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 24 , 1980,p. 85.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) .

Hydralazine Safety Profile

Poison by ingestion, intravenous, intraperitoneal, and subcutaneous routes. Human systemic effects by ingestion: allergic dermatitis, cardiomyopathy, changes in coronary arteries. Human teratogenic effects by an unspecified route: developmental abnormalities of the blood and lymphatic system. Questionable carcinogen. Mutation data reported. When heated to decomposition it emits toxic fumes of NOx.

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View